Debt-to-equity of FENNEC PHARMACEUTICALS INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
FENNEC PHARMACEUTICALS INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • FENNEC PHARMACEUTICALS INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -882%, a 43% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

FENNEC PHARMACEUTICALS INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -882% +659% +43% 30 Sep 2025
Q2 2025 -900% +69% +7.2% 30 Jun 2025
Q1 2025 -1268% -702% -124% 31 Mar 2025
Q4 2024 -2617% -2295% -712% 31 Dec 2024
Q3 2024 -1541% -1152% -296% 30 Sep 2024
Q2 2024 -970% -284% -41% 30 Jun 2024
Q1 2024 -566% -7068% -109% 31 Mar 2024
Q4 2023 -322% -655% -197% 31 Dec 2023
Q3 2023 -389% -510% -422% 30 Sep 2023
Q2 2023 -686% -735% -1503% 30 Jun 2023
Q1 2023 6502% +6465% +17236% 31 Mar 2023
Q4 2022 332% 31 Dec 2022
Q3 2022 121% 30 Sep 2022
Q2 2022 49% 30 Jun 2022
Q1 2022 38% 31 Mar 2022
Q4 2018 6% -2% -21% 31 Dec 2018
Q3 2018 6% -4% -41% 30 Sep 2018
Q2 2018 5% -3% -37% 30 Jun 2018
Q1 2018 6% -4% -42% 31 Mar 2018
Q4 2017 8% -5% -38% 31 Dec 2017
Q3 2017 10% -7% -42% 30 Sep 2017
Q2 2017 9% -18% -67% 30 Jun 2017
Q1 2017 11% -58% -84% 31 Mar 2017
Q4 2016 12% -67% -85% 31 Dec 2016
Q3 2016 17% -97% -85% 30 Sep 2016
Q2 2016 26% +1140% 30 Jun 2016
Q1 2016 69% +262% 31 Mar 2016
Q4 2015 79% +227% 31 Dec 2015
Q3 2015 114% +250% 30 Sep 2015
Q2 2015 -1114% -981% -736% 30 Jun 2015
Q1 2015 -194% -55% -39% 31 Mar 2015
Q4 2014 -147% -16% -12% 31 Dec 2014
Q3 2014 -136% -7% -5.1% 30 Sep 2014
Q2 2014 -133% +21% +14% 30 Jun 2014
Q1 2014 -139% +62% +31% 31 Mar 2014
Q4 2013 -131% -1443% -110% 31 Dec 2013
Q3 2013 -129% -316% -169% 30 Sep 2013
Q2 2013 -154% -2405% -107% 30 Jun 2013
Q1 2013 -201% +1134% +85% 31 Mar 2013
Q4 2012 1312% 31 Dec 2012
Q3 2012 187% 30 Sep 2012
Q2 2012 2250% 30 Jun 2012
Q1 2012 -1335% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.